GSK showcases pipeline momentum across lung, gynaecological and gastrointestinal cancers at ESMO 2026
GSK will present more than 20 abstracts from its expanding solid tumour portfolio at the 2026 ESMO congress
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


